Cargando…
Evaluation of health status in patients with hepatitis c treated with and without interferon
BACKGROUND: The evolution of technology in healthcare has increased the health care’s costs and, the universal healthcare systems, in developed countries, need to ensure proper allocation of resources. Thus, the major issue is assessing the effectiveness of new medical technologies. The evaluation o...
Autores principales: | Ragusa, R., Bertino, G., Bruno, A., Frazzetto, E., Cicciu, F., Giorgianni, G., Lupo, L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773186/ https://www.ncbi.nlm.nih.gov/pubmed/29343250 http://dx.doi.org/10.1186/s12955-018-0842-x |
Ejemplares similares
-
Hepatitis C Virus Infection in Children and Pregnant Women: An Updated Review of the Literature on Screening and Treatments
por: Ragusa, Rosalia, et al.
Publicado: (2020) -
Responsibility of hepatitis C virus in the development of hepatocellular carcinoma: From molecular alterations to possible solutions
por: Bertino, Gaetano, et al.
Publicado: (2018) -
Resveratrol in Hepatitis C Patients Treated with Pegylated-Interferon-α-2b and Ribavirin Reduces Sleep Disturbance
por: Pennisi, Manuela, et al.
Publicado: (2017) -
Improvement of health-related quality of life and psychological well-being after HCV eradication with direct-acting antiviral agents. Real life setting data of an Italian cohort valued by Hepatitis Quality of Life Questionnaire (HQLQv2)
por: Bertino, Gaetano, et al.
Publicado: (2021) -
Rosuvastatin reduces nonalcoholic fatty liver disease in patients with chronic hepatitis C treated with α-interferon and ribavirin: Rosuvastatin reduces NAFLD in HCV patients
por: Malaguarnera, Michele, et al.
Publicado: (2011)